Development of active and passive human vaccines to treat methamphetamine addiction.
about
Customizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applicationsNeuroimmune basis of methamphetamine toxicityThe synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse.Treatment of methamphetamine abuse: an antibody-based immunotherapy approach.Pharmacological approaches to methamphetamine dependence: a focused review.Anti-cocaine vaccine development.Can you vaccinate against substance abuse?Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effectsImpact of distinct chemical structures for the development of a methamphetamine vaccineSynthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines.The anti-(+)-methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-methamphetamine effects on intracranial self-stimulation in rats.Pharmacokinetic strategies for treatment of drug overdose and addiction.Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in ratsVaccines in the Treatment of Substance AbuseSubstance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuseChronic treatment of (+)-methamphetamine-induced locomotor effects in rats using one or a combination of two high affinity anti-methamphetamine monoclonal antibodies.Designing immunotherapies to thwart drug abuse.Immunotherapy Applied to Neuropsychiatric Disorders: a New Perspective of Treatment.Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.Thinking outside the synapse: pharmacokinetic-based medications for cocaine addiction.Intervention Effect of Repetitive TMS on Behavioral Adjustment After Error Commission in Long-Term Methamphetamine Addicts: Evidence From a Two-Choice Oddball Task.Effect of Centruroides antivenom on reversal of methamphetamine-induced hyperkinesis and hyperthermia in rats.Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse.
P2860
Q26864041-E6A70099-407F-4A13-9C93-F4ED13868F76Q28247084-C1C4AE3A-3A6A-41A6-B349-2BEE567A73C0Q33514043-1256EDE1-F692-4ECE-A71B-ECD817FFBA48Q33810798-A9A971A0-1CA4-48BA-86AF-530B55934A16Q33906303-CE6F7EF0-428D-42C1-A5D5-FFCC6C08A968Q34023863-8FBD9767-1091-4D3D-A785-F60A674E9AAEQ34132788-F4159C1F-9716-48F6-AE20-63F06999FD57Q34216479-DA964F94-C086-4C3B-A5CA-374C1F0FBC62Q34956542-F0330A56-95EA-4938-84A5-CB3F0C069740Q35120379-BCC89195-DEF1-44E1-B833-B384834A5A86Q35151502-F613F8AD-FECC-4B53-A352-4BEF4BBF7989Q35813574-F6FAA9CB-8C94-4E21-B365-70A6A5A12EFFQ35875875-B49591B9-09DF-4C5B-9BC5-534C98B54D29Q36579253-94A206FA-113F-42EE-B34A-BE53DF98D06BQ36655861-52777851-023F-48F0-9906-FCB8D634CF26Q37052393-A6FAED48-A124-48CC-8F8A-38582D4F4853Q37082158-A9E78B86-FFB2-478C-94F5-4D3479F49BBBQ37264923-BF0342EC-BE8A-4F58-BE6A-8E3D4B277466Q37346613-D8EFDD99-973D-436E-B983-D9DB81934B6DQ38508754-C8EA2F02-58E3-498F-A65C-CD9E2E6AF40FQ39107792-202826F7-66A7-4530-B27C-AB3C715F57B4Q42577570-8181E56A-7EB1-4295-A6EC-1D45082645F5Q48230062-65F7658C-6E03-45A8-80D7-38E7F1682E64Q49278260-4DA61FF9-7F79-4650-89CE-AD31393C5F5DQ55471442-59C9ACA9-58C3-46BD-A759-BE90B1F543F6
P2860
Development of active and passive human vaccines to treat methamphetamine addiction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of active and passive human vaccines to treat methamphetamine addiction.
@en
Development of active and passive human vaccines to treat methamphetamine addiction.
@nl
type
label
Development of active and passive human vaccines to treat methamphetamine addiction.
@en
Development of active and passive human vaccines to treat methamphetamine addiction.
@nl
prefLabel
Development of active and passive human vaccines to treat methamphetamine addiction.
@en
Development of active and passive human vaccines to treat methamphetamine addiction.
@nl
P2093
P2860
P356
P1433
P1476
Development of active and passive human vaccines to treat methamphetamine addiction.
@en
P2093
Daniela Rüedi-Bettschen
S Michael Owens
W Brooks Gentry
P2860
P304
P356
10.4161/HV.5.4.7456
P577
2009-04-20T00:00:00Z